Sabinsa Corporation submits L-selenomethionine specification to U.S. Pharmacopial Commission

May 9, 2025
Share this article:
Sabinsa Corporation submits L-selenomethionine specification to U.S. Pharmacopial Commission

The Sabinsa Corporation of East Windsor, New Jersey announces the submission of specifications on L-Selenomethionine to the United States Pharmacopoeial Commission.

According to the company, L-Selenomethionine is the safest, most efficacious form of selenium. Due to its organic structure, it is more bioavailable than inorganic forms such as sodium selenite. Sabinsa is the first U.S. based company to manufacture the pure compound.

Recognition of L-Selenomethionine in the USP would increase awareness of quality related products in health food and nutritional supplement formulations.

 

 

You might also like

Latest Blogs

Latest Blogs

View All
Latest Events

Latest Events

View All
Latest Media Coverage

Latest Media Coverage

View All
Possibilities Background

Explore endless possibilities with us.
Let’s connect and make it happen!

Get In Touch